A Study to Determine Enzalutamide Long-term Safety and Efficacy After Anti-androgen Therapy for CRPC
NCT02669147
·
clinicaltrials.gov ↗
COMPLETED
Status
160
Enrollment
OTHER
Sponsor class
Conditions
Castration Resistant Prostate Cancer (CRPC)
Sponsor
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan